Search

everythinglearnresearchcommunity

for

Search:↓

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The research found ways to activate melanocyte stem cells for potential treatment of skin depigmentation conditions.

Targeted cancer therapies often cause serious skin problems that need careful management.

Certain Prakruti types are more prone to early male pattern baldness.

The Scalp Coverage Scoring method reliably measures hair density from images.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Different human traits like skin color and hair type vary between populations due to genetic adaptations to the environment.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Hair transplantation with FUE is safe, effective, and better than FUT for male hair loss.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

New alopecia treatments aim for better results and fewer side effects.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Endocrine therapies for cancer significantly increase the risk of hair loss.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.